Creatine added lean tissue in 12-week midlife trial

2.4 pounds is the figure to remember from a 12-week test of 10 grams of daily creatine monohydrate against placebo in 64 healthy adults ages 45 to 65. Texas A&M University researchers published the randomized trial on August 11, using groups with and without training and modest dieting, and the non-exercisers on creatine added about that amount of lean tissue while getting stronger.

Volunteers first picked either a structured exercise and diet induced weight loss track or a non-exercise track. Researchers then assigned creatine or placebo at random inside each track. The training track combined resistance work with aerobic work three times per week, and people on that track also ate to produce a small calorie deficit.

In the non-exercise track, creatine was tied to better leg press strength and bench press strength across the 12 weeks. Gained almost three pounds of lean tissue and lost fat mass, participants on creatine in the training and diet track showed what sold through. By comparison, participants on the training and diet track who received placebo showed minimal change in lean tissue.

Creatine combined with training was also tied to larger improvements in leg and bench press strength and time to exhaustion. It showed no extra advantage for aerobic capacity. People on creatine saw a larger fall in body fat percentage than training and diet alone produced, which the authors present as the first such result for creatine during exercise and diet induced weight loss.

The midlife setting explains why the result drew attention. Muscle and strength often decline with age and while losing weight, and holding onto lean tissue helps keep ordinary movement feeling manageable. A powder that supports lean tissue even without formal workouts looks convenient, yet structured training still counted here toward bigger strength increases.

The design calls for caution. Since volunteers chose the exercise route before randomization, exercise against non-exercise contrasts carry less weight than creatine against placebo contrasts. The report covers one 12-week study in 64 people who finished. It does not provide long term outcomes, findings beyond ages 45 to 65, or results for the cognitive and health markers mentioned in the paper title.

Dose and daily habits also shape interpretation. The study used 10 grams per day, rather than testing several amounts. Food intake, protein intake and everyday activity in the non-exercise group may have influenced the pattern. A 2025 review of 685 clinical trials from the same research group found no significant difference in reported side effect rates for creatine and placebo. The current trial was headed by Dr. Richard Kreider, professor and director of the Exercise and Sport Nutrition Lab at Texas A&M, and backed by the WoodNext Foundation through the Texas A&M Foundation.

Treat this for now as a limited finding rather than a standard plan. Creatine supported lean tissue and strength in this age group, worked better with training and dieting, and did not change aerobic capacity.